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Abstract. Transformation of circulating leukocytes from a dormant into an activated state with changing rheological properties
leads to a major shift of their behavior in the microcirculation. Low levels of pseudopod formation or expression of adhesion
molecules facilitate relatively free passage through microvessels while activated leukocytes with pseudopods and enhanced
levels of adhesion membrane proteins become trapped in microvessels, attach to the endothelium and migrate into the tissue.
The transformation of leukocytes into an activated state is seen in many diseases. While mechanisms for activation due to infec-
tions, tissue trauma, as well as non-physiological biochemical or biophysical exposures are well recognized, the mechanisms
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for activation in many diseases have not been conclusively liked to these traditional mechanisms and remain unknown. We sum-
marize our recent evidence suggesting a major and surprising role of digestive enzymes in the small intestine as root causes for
leukocyte activation and microvascular disturbances. During normal digestion of food digestive enzymes are compartmental-
ized in the lumen of the intestine by the mucosal epithelial barrier. When permeability of this barrier increases, these powerful
degrading enzymes leak into the wall of the intestine and into the systemic circulation. Leakage of digestive enzymes occurs
for example in physiological shock and multi-organ failure. Entry of digestive enzymes into the wall of the small intestine leads
to degradation of the intestinal tissue in an autodigestion process. The digestive enzymes and tissue/food fragments generate
not only activate leukocytes but also cause numerous cell dysfunctions. For example, proteolytic destruction of membrane re-
ceptors, plasma proteins and other biomolecules occurs. We conclude that escape of digestive enzymes from the intestinal track
serves as a major source of cell dysfunction, morbidity and even mortality, including abnormal leukocyte activation seen in
rheological studies.
Keywords: Intestine, pancreas, digestive enzyme, intestinal mucosa, permeability, trypsin, chymotrypsin, elastase, lipase,
matrix metalloproteinases, diabetes, hypertension, metabolic disease
1. Introduction
With deep gratitude I thank the International Society for Biorheology for selection of my name as the
Poiseuille Award winner. As student of the microcirculation it is a special privilege to be associated with
the name of Jean Léonard Marie Poiseuille, whose famous law embraces some of the most fundamen-
tal aspects of hemodynamics in small blood vessels. It is a special honor to join the list of esteemed
Poiseuille Award winners.
The study of blood rheology has served as point of departure to understand important aspects about
living tissues in molecular detail. As student I had the great fortune to join Benjamin Zweifach and Yuan-
Cheng Fung at the University of California San Diego and later as postdoctoral fellow continue this work
with Shu Chien and Richard Skalak at Columbia University, all pioneers in blood rheology. I studied
leukocyte rheology, at a time when blood rheology was largely focused on red cells and platelets. The
interest in leukocyte rheology was only starting. The biophysical and rheological properties of leukocytes
were largely unknown and there was an opportunity to develop a deeper understanding of their behavior
in-vivo.
In the following I will give a brief summary of selected observations about these cells in the microcir-
culation. The study of the rheological properties of leukocytes in-vitro and in-vivo opened an important
gateway to analyze disease states at a new level of detail. Indeed, the study of leukocytes led eventually
after a long and winding exploratory tour to a new idea about the origin of human disease and death,
which we designated as “Autodigestion”. It would not have been possible without an understanding of
leukocytes in-vivo.
2. Microvascular perfusion and leukocytes activation
Leukocytes have the ability to obstruct the microcirculation and generate states of immune-
incompetence. In spite of their relatively small numbers in the blood circulation, leukocytes can play
a major role in perfusion of a capillary network. Their morphology [1,2] and stiff cytoplasmic viscoelas-
tic properties is dramatically different compared to that of the highly deformable red cells [3–5]. In
addition leukocytes have the ability to spontaneously change their cytoplasmic properties transforming
from a viscoelastic to an elastic cytoplasm by localized actin polymerization and cross linking, a process
that leads often to projection of stiff pseudopods. Leukocytes control membrane adhesion by expression
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and activation of specific membrane receptors which in turn orchestrate a sequence of events that serves
to attach the cell to the endothelium and facilitate transendothelial migration, a process that has been
subject to numerous investigations [6–12].
Circulating leukocytes control microvascular perfusion in capillaries, and they do so by influencing
the motion of the red cells [13,14]. Leukocytes (e.g. granulocytes or monocytes) in single file capillaries
are less deformed compared to the highly flexible red cells and therefore move slower [15]. The velocity
difference between the two cell types leads to formation of “leukocyte–erythrocyte trains” [16] visible
to a person in their own retina [17]. The leukocytes disturbed the slower moving red cells, an effect that
causes an increase of the apparent viscosity controlled by the red cells in capillaries with an increase in
whole organ hydrodynamic resistance [13,14].
A severe microvascular disturbance by leukocyte occurs when they are trapped in capillaries. Leuko-
cytes that obstruct capillaries generate the capillary no-reflow phenomenon [18]. Capillary obstruction
can occur by multiple mechanisms, when the microvascular perfusion pressure is reduced [19–21], when
capillary endothelium projects pseudopods [22] or undergoes apoptosis [23], and/or when leukocytes
become activated. The leukocyte activation is detected by the presence of cells with pseudopods, by an
altered expression of membrane adhesion molecules, by spontaneous degranulation, and even by bio-
chemical indicators such as enhanced release of oxygen free radicals, all of which without indications
for cell death (apoptosis or necrosis). Activation with pseudopod formation retards leukocytes in the
microcirculation, may cause their entrapment and further raises the hemodynamic resistance [14,24].
Activated leukocytes can be observed in many different diseases as well as in the presence of risk factors
for disease [25–29]. This evidence that the state of activation controls basic hemodynamics brought to
light the importance of leukocyte activation in disease.
3. Transformation of the leukocyte rheological properties in disease
Leukocyte, in the free circulation or when attached to the endothelium, become activated as an early
step in the inflammatory cascade and eventual tissue repair. While leukocytes require several cellular
mechanisms to migrate or to phagocytize, in the free circulation most of these mechanisms remain in a
relatively dormant state. Specifically, it is rare to find in a normal microcirculation of a healthy individual
leukocytes with pseudopods (Fig. 1). In fact the fluid shear stress in the circulation serves to stimulate
retraction of pseudopods [30] by a mechanism that involves membrane receptors [31] and interaction
with red cells [32]. Fluid shear stress at levels encountered in the circulation also reduce membrane
adhesion [33]. The majority of leukocytes collected by venous phlebotomy of non-symptomatic control
individuals shows low levels of leukocyte activation.
In contrast, in diseases or in the presence of risks for diseases the number of circulating leukocytes
forming pseudopods, or expressing oxygen free radicals, is notably increased [26,34–36]. The enhanced
level of leukocyte activation is detected in freshly drawn blood samples, even though activated leukocytes
may not stay in the active circulation due to capillary entrapment. Evidence for leukocyte activation
can also be detected by use of naive leukocytes from a healthy donor exposed in-vitro to plasma from
patients. In experimental hemorrhagic shock, during a transient (1 to 2 hours) reduction of the central
arterial blood pressure it is possible to predict with high probability the mortality 24 hours after shock
by the level of leukocyte activation before shock [37]. These observations suggest that the study of
leukocyte activation can serve as a tool to explore mechanisms leading to acute organ failure in shock,
and thereby provide insight into a severe pathogenic event.
182 G.W. Schmid-Schönbein / The autodigestion hypothesis: Proteolytic receptor cleavage
Fig. 1. Scanning electron micrograph of fresh, untreated, circulating leukocytes (predominantly neutrophils and monocytes) in
venous blood derived from the free circulation. Cells in the top row have low levels of pseudoformation and represent a non-ac-
tivated (passive) state, and in bottom row exhibit an activated state with extensive pseudopods. Leukocytes of non-symptomatic
healthy controls are rare in non-symptomatic control individuals but occur more frequently in circulating leukocytes of individ-
uals with disease symptoms. Activation of circulating leukocytes may be accompanied by expression of membrane adhesion
molecules, endothelial adhesion, oxygen free radical formation, degranulation, depletion glycocalyx, reduced response to fluid
shear stress and other forms of cell activity. Length of bars is 1 μm.
We took advantage of this opportunity to search for mechanisms for the activation derived from the
plasma during hemorrhagic shock. The activation is easily detectable and reproducible when plasma
collected during shock is exposed to naive donor leukocytes.
4. Mechanisms leading to leukocyte activation
Healthy animals have a low levels of cell activation. In contrast less than an hour after central blood
pressure reduction elevated levels of cell activation are detected. This can be see on leukocytes from
unseparated venous blood, but is also observed when plasma of animals collected during the shock
period is separated and applied to naive donor control leukocytes [38] indicating that a factor in plasma
is involved in the activation. An understanding of the mechanism(s) that causes this activation seemed
to us essential to identify the source for microvascular defects in hemorrhagic shock.
Our group and others searched over several years for specific biochemical inflammatory mediators(s)
that may be present in the plasma and responsible for activation of leukocytes. Our initial hypothe-
sis followed traditional thinking that there is a mediator in the plasma (e.g. endotoxins, complement
components, reactive oxygen species, lipid mediators) that may be responsible for the activation [39].
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Some of these mediators may not only serve to activate but may also be cytotoxic by themselves or as a
mixture of different mediators [40,41]. We and others found mediators in the plasma (e.g. complement
components, fibronectin fragments). But an important control experiment by removal of the mediators
from plasma (e.g. by immunoaffinity columns) or blockade of their signaling pathways (e.g. by recep-
tor blockade) did not eliminate the ability of the shock plasma to activate leukocytes, undermining the
hypothesis that single biochemical mediator(s) were causing the activation. We were not able to abolish
activation of naive cell exposed to plasma collected during hemorrhagic shock. The specific mecha-
nism(s) by which plasma may produce cell activation remained uncertain. After years of attempts to
identify the inflammatory mediators with classical biochemical approaches [39] we recognized the need
for a new approach to this fundamental problem in the pathogenesis of hemorrhagic shock.
5. Cell activation in hemorrhagic shock
Even relatively short periods of hemorrhagic shock (∼40 minutes; [38]) can lead to elevated levels
of leukocyte activation in the circulation. This evidence suggests that little de-novo gene expression
and protein biosynthesis is required to generate the mediator in shock plasma. Since hemorrhagic shock
is induced merely by central blood pressure reduction and no biochemical agents are administered to
produce organ failure (as compared with endotoxic shock, in which endotoxin needs to be introduced
into the circulation), cell activation is caused by a mechanism that involves biomolecules already present
in a normal animal before shock.
What could be the source? We obtained an important lead by closer examination of different organs.
6. Pancreatic digestive enzymes
In hemorrhagic shock with central blood pressure reduction all organs are temporarily hypo-perfused
with reduced oxygen delivery. Thus any organ, tissue or cell may become a source of mediators that
causes the leukocyte activation. But the particular organ(s) that may be involved were unknown. This
opportunity lead to a systematic search among organs and served to identify the pancreas as a major
source for mediator of leukocyte activation in shock [42,43]. In addition to the pancreas, the intestine also
served as a major source, but only if it contains digestive enzymes. If digestive enzymes are rinsed out
of the lumen of the small intestine, the wall of the intestine by itself produces low leukocyte activation,
comparable to other organs. This evidence led us to the hypothesis that digestive enzymes synthesized
in the pancreas and discharged into the small intestine, as part of daily digestion, may in fact be a source
for mediators of the leukocyte activation.
We demonstrated that pancreatic digestive enzymes, including trypsin, are able to produce powerful
activating mediators not only for leukocytes but also for other cell types in the microcirculation and
surrounding tissues [44]. These mediators may be hydrophilic (e.g. unbound free fatty acids) or hy-
drophobic (e.g. proteolytically generated peptides) and produce a pathophysiologic response sufficient
to cause lethal shock [45–47].
The evidence points directly at a central role for the digestive enzymes in multi-organ failure. They
are largely synthesized in the pancreas and discharged into the duodenum at the proximal segment of the
small intestine as part of daily digestion where they are fully activated, relatively non-specific and con-
centrated. What had started as a narrow search for mediators of leukocyte activation led to a mechanism
with a much broader spectrum of activities, in line with the many pathophysiological events in shock.
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7. Escape of digestive enzymes across the mucosal barrier
While normally contained in the lumen of the small intestine, in shock the pancreatic digestive en-
zymes escape across the mucosal barrier into the wall of the intestine and from there into the systemic
circulation [48,49]. The mucosal barrier consists mainly of the intestinal epithelium with interdispersed
goblet cells coated with a continuous mucin layer. The mucin layer forms a barrier for the digestive
enzymes, like trypsin, chymotrypsin or elastase with molecular weights in the range between 20K and
30K Dalton. Escape of digestive enzymes out of the lumen of the intestine due to an enhanced mucosal
barrier permeability [48] leads to their passage into the interstitial tissue (lamina propria) of the intestinal
villi. Zymography shows digestive enzyme activity inside the villi and even in the muscularis and outer
serosa layers.
In the intestinal wall digestive enzymes gain access to the venous system of the intestine, the intestinal
lymphatics, and to the peritoneum. Thus all possible anatomical pathways serve digestive enzymes to
escape from the lumen of the intestine into the systemic circulation [49]. Digestive enzymes utilize
mostly convective transport during escape from the lumen of the intestine into the central circulation,
transport by diffusion is relatively inefficient considering their molecular weight.
8. Autodigestion
During leakage from the intestinal lumen active digestive enzymes cause major morphological dam-
age to the mucosal barrier [48,50,51]. The tissue degradation starts at the tip of villi (Fig. 2), a tissue
region with frequent apoptosis, and may progress until the entire villi structures are degraded [50,52]
including blood vessels and lymphatics in their interior. The intestinal barrier may become degraded, ex-
posing autologous tissue without protection from the undiluted and high concentrations of the digestive
enzymes. There can be a catastrophic digestion of the intestine.
9. Proteolytic receptor cleavage and cell dysfunction
Escape of digestive proteases, like trypsin, out of the small intestine leads to activation of other en-
zymes, e.g. matrix-metallo proteinases (MMPs). In the presence of an ischemic intestine the proMMP-9
of neutrophils is activated into active MMP-9 [53] in many organs, e.g. liver, lung, heart and brain [54].
Another consequence of the escape of pancreatic digestive enzymes out of the lumen of the intestine
is that they cleave membrane receptors. Serine proteases, like trypsin or chymotrypsin, are initially
extracellular and active to cleave any protein; this includes the ability to clip the extracellular domain of
membrane receptors. We have shown in-vitro that extracellular digestive enzymes impair the ability of
endothelial cells to align in the direction of fluid shear and they cleave the glycocalyx and membrane
receptors (e.g. VEGR-2 or the insulin receptor) [55].
Entry of digestive proteases into the systemic circulation leads to cleavage of the extracellular domain
of the insulin receptor and consequently loss of the ability to bind insulin and signal glucose transport.
The consequence is hyperglycemia with attenuated response to an insulin bolus, i.e. acute insulin resis-
tance. Blockade of the digestive proteases in the lumen of the small intestine prevents elevation of the
digestive enzyme activity in the systemic circulation, and abolishes the insulin receptor cleavage and
with it indicators for insulin resistance [56]. Insulin resistance in a chronic model is also inhibited by
prolonged protease inhibition [57].
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Fig. 2. Example of small intestine histological section before (top image) and after hemorrhagic shock (with 35 mmHg mean
arterial pressure for 2 hours) (bottom). Note the extensive damage to the tip of the intestinal villi (arrows), a feature that is due
to entry of digestive enzymes into the wall of the intestine and causes extensive autodigestion of intestinal tissue, actual loss of
epithelium and connective tissue in the villi and swelling of the muscularis layer (small arrow). The autodigestion of tissue is
minimized if digestive enzymes in the lumen of the small intestine are inhibited. The autodigestion of intestinal tissue is present
in many forms of shock in addition to hemorrhagic shock [51]. Length of bars is 100 μm.
The ability of the digestive enzymes to directly or indirectly (via activation of MMPs) compromise cell
dysfunctions by proteolytic destruction of membrane receptors appears to be a universal phenomenon.
It may underlie many pathogenic mechanisms in multi-organ dysfunction and failure, including rheo-
logical dysfunctions. For example, the fluid shear stress response of leukocytes with retraction of pseu-
dopods is compromised by MMPs due to cleavage of the FMLP-receptor (FPR) [58]. The glycocalyx
on red cells [59] and on the endothelium can be cleaved by MMPs [60–62]. We detected cleavage of the
inter-epithelial adhesion receptor E-cadherin in the intestine, occludin, VE-cadherin, and VEGFR2 in
the lung after hemorrhagic shock [63]. The toll-like receptor in the intestine is cleaved during ischemia
(TLR4) [48]. There seem to be a large number of membrane receptors whose extracellular domains may
be clipped by MMPs, digestive proteases and others.
10. Blockade of digestive enzymes in the lumen of the small intestine
Enteral blockade of the digestive enzymes in the lumen of the intestine during shock has many bene-
ficial effects in addition to prevention of rheological dysfunction or the acute insulin resistance. It serves
to preserve organ morphology, attenuate the cell damage in the small intestine and its villi structures
[51,64,65]. It reduces hemorrhagic lesion formation in the microvasculature with escape of whole blood
into the surrounding tissue (e.g. in the lung, heart muscle), attenuates damage to the cardiac muscle and
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serves to maintain systemic blood pressure in different forms of shock. Enteral blockade of digestive en-
zymes decreases long-term mortality rates and enhances the recovery rate of body weight and intestinal
function in relatively severe forms of hemorrhagic and septic shock [51]. The broad protection against
organ failure and mortality is provided by different types of molecules used to block digestive proteases.
Further insight into the critical role of digestive enzymes for the outcome of septic shock is illustrated
by enteral digestive protease inhibition in the case of gram-negative endotoxin shock. These experiments
support the idea that endotoxin per se is not solely responsible for organ failure and instead utilizes
another pathway to facilitate organ failure. Intravenous endotoxin administration causes elevation of the
permeability in the endothelium and epithelium. The elevated permeability of the mucosal barrier allows
escape of the digestive enzymes out of the lumen of the small intestine into the central circulation. The
subsequent organ failure and death is then mediated by digestive proteases, in line with the evidence
that their enteral blockade significantly attenuates organ failure in endotoxic shock [65]. This interesting
observation suggests the hypothesis that infectious agents (and not just endotoxins) induce a breakdown
of the mucosal barrier which then allows the leakage of the digestive enzymes out of the lumen of
the small intestine. Thus the pathogenic effects of infectious agents may require an involvement of
digestive enzymes. This idea needs to be tested in the future and may open new treatment opportunities
for infections.
Formal experiments to test enteral blockade of digestive enzymes as a clinical intervention remain to
be carried out. In 2010 enteral blockade of the pancreatic digestive proteases was successfully applied
the first time in a septic patient. As noted in this report [66] enteral infusion of a trypsin inhibitor
(gabexate Mesilate) resulted in a rapid reversal of the indicators of a systemic inflammatory response
and the sequelae of septic shock within 72 hours.
11. What mechanisms may open the mucosal barrier?
These results support the hypothesis that escape of digestive enzymes across the mucosal barrier in
the intestine is a problem that different forms of shock may have in common. Any breach of the mucosal
barrier allows these enzymes to escape with potentially deadly consequences [67].
The question then arises, what mechanism may open the mucosal barrier? The answer to this impor-
tant question likely depends on specific circumstances and the type of inflammatory mediators present.
The barrier can be opened by reduced perfusion and reduction of ATP levels – be it by local vascular
occlusions in the intestine or by central blood pressure reduction, such as splanchnic artery occlusion
or hemorrhagic shock, respectively. The barrier can also be opened without ischemia in the presence of
inflammatory mediators, such as endotoxins and many others, that target inflammatory pathways in the
epithelium or epithelial cell apoptosis. Furthermore, the mucosal barrier may also be opened by cyto-
toxic mediators that are generated during digestion of food (e.g. unbound free fatty acids) and that are
small enough to breach the mucosal barrier to cause death in epithelial cells. Free fatty acids are derived
from breakdown of triglycerides by pancreatic digestive lipase. If free fatty acids remain unbound (as
compared to micelle formation) they are cytotoxic since they dissolve in lipid bilayers and destroy them
[68]. It is interesting to note in this regard that removal of food and partially digested food from the
lumen of the intestine reduces injury to the intestinal wall in hemorrhagic shock [63].
During normal digestion, the transport of digestive enzymes across the mucosal barrier is to a large
degree blocked by the mucin layer and the epithelium [48]. In a normal intestine dextran at molecular
weight of 20 kDa, comparable to the molecular weight of pancreatic trypsin, only minimally passes
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across the mucin layer [50]. This observation is also supported by direct protease measurements in the
intestinal wall of control animals suggesting that the digestive enzymes per se are normally kept to a large
degree by the mucin barrier in the lumen of the intestine [48]. Mucin, as a highly hydrated molecule,
seems to be optimized to prevent its cleavage by digestive enzymes in the lumen of the intestine.
This evidence indicates that a separate mechanism in the mucin/epithelial layers is involved with
elevation of the mucosal barrier permeability for molecules the size of digestive enzymes. The mucin
layer and epithelium of the mucosal barrier require metabolic and signaling processes to maintain a
state of low permeability to digestive enzymes; failure of any one of them serves to open pathways for
transport across the mucin and the epithelial cells into the underlying connective tissue in the intestinal
villi (e.g. the lamina propria). They include metabolic support for ATP production, intact cell adhesion
mechanisms (e.g. adherence and tight junctions by E-cadherins, occludin, claudin, JAM, desmosomes),
synthesis of mucin and integrin attachment of epithelial cells to the basal lamina and the lamina propria.
Failure of the mucin layer provides trypsin and the other digestive enzymes access to intercellular
junctions and cleavage of the extracellular domain of junction proteins and thereby starts the process
that leads to breakdown of the mucosal barrier. Digestive enzymes destroy the epithelial lining and its
tight junction proteins [69]. Such autodigestion is a catastrophic event since the mucosal barrier is then
breached so that all wall structures of the intestine are exposed without a barrier to the digestive enzymes
in the lumen [52].
12. Conclusion
What started decades ago as a question about the mechanisms for leukocyte activation in plasma has
led to a surprising new focus: digestive enzymes. Synthesized in the pancreas and carried in the small
intestine as part of normal daily digestion, these powerful enzymes may escape across the mucosal bar-
rier and play a central role in cell and organ dysfunction. In the systemic circulation they may degrade
membrane components, which in turn triggers diverse cell dysfunctions. For example, cleavage of the
ectodomain of membrane receptors on leukocytes impairs their response to fluid shear stress or adhe-
sion to the endothelium, and cleavage of the insulin receptor leads to insulin resistance. Cleavage of the
glycocalyx influences red cell aggregation and other biorheological properties of blood. In physiologi-
cal forms of shock we now have evidence to indicate that besides cell dysfunctions digestive enzymes
can cause organ failure and death (Fig. 3). It is interesting to think about the possibility that digestive
enzymes not only digest food but may also autodigest one’s own tissues. If this idea is confirmed, we
may have gained fundamental new insight into disease and death.
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Fig. 3. Schematic diagram of key events during the transition from normal digestion into autodigestion and its extensive con-
sequences in the central circulation, including leukocyte activation, blood rheological changes to the point of full organ failure.
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